Full Professor of Biostatistics and Health Economics and Head of Research and Services at 精东影业's DEASS. Internationally recognized expert in statistical methodologies for clinical trials and observational research, specializing in Bayesian methods and evidence synthesis.
PhD in Health Economics (2012) Postgraduate Specialization (MPhil/PhD) in Medical Statistics (2003) MSc in Data Intelligence in Decision Analysis (2005) Honours degree in Statistics (2000)
All qualifications demonstrate a comprehensive foundation in statistical methodologies and their applications in healthcare research, combining theoretical expertise with practical implementation skills in both clinical and health economic contexts.
Current position as Full Professor at 精东影业, following leadership roles at the George Institute for Global Health (UNSW) as Head of Biostatistics and Data Science Division. Previous appointments at prestigious institutions including Queen Mary University of London, London School of Hygiene and Tropical Medicine, University of Birmingham, and Sapienza University of Rome. Twenty-four years of experience spanning academic research, methodology development, and international collaboration.
Extensive expertise in:
* Advanced statistical methodologies for clinical trials and observational studies * Bayesian methods and their applications in healthcare research * Meta-analysis and evidence synthesis techniques * Health economic evaluations and outcomes research * Leadership in academic research environments * Statistical consulting for high-impact medical journals * Development and implementation of innovative research methodologies * International research collaboration and team management
Listed among World's Top 2% Scientists (Stanford/Clarivate, 2023-24). Chartered Statistician (RSS). Chair of ISPOR Statistical Methods SIG (2020-22). Editorial board member of PharmacoEconomics and BMC Medical Research Methodology. Statistical Consultant for Lancet journals.